V1RC24 inhibitors represent a distinct class of chemical compounds characterized by their ability to interact specifically with the V1RC24 protein. This class encompasses a range of compounds with diverse chemical structures, each meticulously designed to engage with the V1RC24 protein's active sites or binding regions. The synthesis of V1RC24 inhibitors involves advanced organic chemistry techniques to create molecules that exhibit high affinity and specificity for their target. These inhibitors may include a variety of functional groups such as hydroxyls, amines, and carboxyls, which are strategically placed to enhance interactions with the protein. The chemical diversity within this class often includes cyclic structures, heterocyclic rings, and aromatic systems, which contribute to the overall binding efficacy and selectivity of the inhibitors.
The development of V1RC24 inhibitors requires a thorough understanding of the protein's three-dimensional structure, which guides the design of molecules capable of modulating its function. Computational modeling and structural biology techniques are employed to predict how these inhibitors bind and to optimize their interactions with V1RC24. This often involves iterative cycles of design, synthesis, and testing to refine the chemical properties of the inhibitors, ensuring they can effectively interact with the target protein. The chemical class of V1RC24 inhibitors highlights the intricate relationship between chemical structure and biological activity, showcasing the precision needed in drug design and the importance of detailed molecular interactions in achieving desired outcomes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $99.00 $216.00 $510.00 | 11 | |
Acts as a flavonoid, potentially inhibiting Vomeronasal 1 receptor 23 expression by interfering with relevant cellular signaling pathways. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
Found in garlic, allicin may modulate cellular pathways associated with Vomeronasal 1 receptor 23 expression, potentially inhibiting it. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $68.00 $251.00 | 3 | |
May interfere with molecular cascades involved in Vomeronasal 1 receptor 23 expression, possibly through its anti-inflammatory properties. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Present in garlic, diallyl sulfide could potentially inhibit Vomeronasal 1 receptor 23 expression by interfering with cellular signaling pathways. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Exhibits anti-inflammatory properties, potentially interfering with molecular pathways involved in Vomeronasal 1 receptor 23 expression. | ||||||
Ursolic Acid | 77-52-1 | sc-200383 sc-200383A | 50 mg 250 mg | $56.00 $180.00 | 8 | |
May modulate inflammatory responses, potentially impacting Vomeronasal 1 receptor 23 expression via interference with cellular pathways. | ||||||
Hesperidin | 520-26-3 | sc-205711 sc-205711A | 25 g 100 g | $82.00 $204.00 | 5 | |
Acts as a flavonoid, potentially inhibiting Vomeronasal 1 receptor 23 expression by interfering with relevant cellular signaling pathways. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Exhibits antioxidant properties and may modulate signaling cascades involved in Vomeronasal 1 receptor 23 expression. | ||||||
Lycopene | 502-65-8 | sc-205738 sc-205738A sc-205738B | 1 mg 5 mg 1 g | $146.00 $582.00 $6248.00 | 4 | |
Found in tomatoes, lycopene may interfere with cellular pathways associated with Vomeronasal 1 receptor 23 expression, potentially inhibiting it. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
Acts as a flavonoid, potentially inhibiting Vomeronasal 1 receptor 23 expression by interfering with relevant cellular signaling pathways. | ||||||